A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia

Update Il y a 4 ans
Reference: NCT01034410

Woman and Man

Extract

This is an open label randomized controlled phase II study of AS1411 combined with Cytarabine in the treatment of patients with primary refractory or relapsed acute myeloid leukemia.


Inclusion criteria

  • Acute Myeloid Leukemia


Links